Possibility of molecular targeting therapy for the treatment of cancer of unknown primary origin by analysis of intracellular signaling molecules

Author：                

Publisher： Spandidos Publications

ISSN： 1792-0981

Source： Experimental and Therapeutic Medicine, Vol.3, Iss.3, 2012-01, pp. : 547-549

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Molecular Diagnosis of the Tissue of Origin in Cancer of Unknown Primary Site: Useful in Patient Management

By Greco F.  

Current Treatment Options in Oncology, Vol. 14, Iss. 4, 2013-12 ,pp. : 634-642

Springer Publishing Company

Access to resources Recommend Favorite

Targeting c-KIT, PDGFR in cancer of unknown primary: a screening study for molecular markers of benefit

By Dova L.   Pentheroudakis G.   Golfinopoulos V.   Malamou-Mitsi V.   Georgiou I.   Vartholomatos G.   Ntemou A.   Fountzilas G.   Pavlidis N.  

Journal of Cancer Research and Clinical Oncology, Vol. 134, Iss. 6, 2008-06 ,pp. : 697-704

Springer Publishing Company

Access to resources Recommend Favorite

Targeting hypoxia cell signaling for cancer therapy

By Melillo Giovanni  

Cancer and Metastasis Reviews, Vol. 26, Iss. 2, 2007-06 ,pp. : 341-352

Springer Publishing Company

Access to resources Recommend Favorite

Targeting Intracellular Calcium Signaling ([Ca2+]i) to Overcome Acquired Multidrug Resistance of Cancer Cells: A Mini-Overview

By Büsselberg Dietrich   Florea Ana-Maria  

Cancers, Vol. 9, Iss. 5, 2017-05 ,pp. : 48-48

MDPI

Access to resources Recommend Favorite

Comparison of a gene expression profiling strategy to standard clinical work-up for determination of tumour origin in cancer of unknown primary (CUP)

By Ades Felipe  

Journal of Chemotherapy, Vol. 25, Iss. 4, 2013-8 ,pp. : 239-246

Maney Publishing

Access to resources Recommend Favorite